Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC)

NCT02054793 is registered in ClinicalTrials.gov with Emmanuel Antonarakis, MD as lead sponsor.

NCT NCT02054793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02054793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC)
Lead sponsor
Emmanuel Antonarakis, MD
Phase
Phase 1/2
Overall status
Withdrawn
Start date
June 30, 2014
Completion date
July 31, 2016
Enrollment
0 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

castration-resistant prostate cancer, prostate cancer